LYRA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.291 USD | -0.34% |
|
+6.99% | -94.45% |
| Jul. 01 | Lyra Therapeutics, Inc.(NasdaqGM:LYRA) added to Russell Small Cap Comp Value Index | CI |
| Jul. 01 | Lyra Therapeutics, Inc.(NasdaqGM:LYRA) added to Russell Small Cap Completeness Index | CI |
Evolution of the average Target Price on Lyra Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
5c5863c9a078fb164f0b1.9G8aaoUNUkIjvsZqqu_xIw2cT-nhMBe_WfljCxZaac4.vD1TPO5mahMQx6M-zYabZkH-DZ6ie0fbKLYmaEM2W5SBW1853HoFdFbPiw~04ff6cc32e8f4bcd942a3ef6c22594cd
More recommendations
Analysts' Consensus
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
5
Last Close Price
0.291
USD
Average target price
4.5
USD
Spread / Average Target
+1,446.39%
High Price Target
11
USD
Spread / Highest target
+3,680.07%
Low Price Target
0.5
USD
Spread / Lowest Target
+71.82%
Consensus detail
Consensus revision (last 18 months)
Analysts covering Lyra Therapeutics, Inc.
| HC Wainwright | |
| Jefferies & Co. | |
| BTIG | |
| BofA Securities | |
| Cantor Fitzgerald |
Trading Rating
Investor Rating
ESG Refinitiv
C
EPS Revisions
- Stock Market
- Equities
- LYRA Stock
- Consensus Lyra Therapeutics, Inc.
